The shortage of antivenoms can be attributed to several factors, including high production costs, limited commercial incentives, and logistical challenges in distribution. In some regions, particularly in developing countries, the demand for antivenoms exceeds supply, leading to significant public health concerns. Efforts are being made to improve accessibility and affordability through international collaborations and research initiatives.
